N🟁N

Biorem reports second quarter results

  //business-finance.news-articles.net/content/2010/08/19/biorem-reports-second-quarter-results.html
  Published in Business and Finance on Thursday, August 19th 2010 at 14:05 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

 Financial Summary: ----------------------------------- Three-months Six-months ended June 30, ended June 30, ------------------------------------------------------------------------- (in thousands of Canadian dollars, except percent and per share data) 2010 2009 2010 2009 ------------------------------------------------------------------------- REVENUE $4,560 $5,678 $7,808 $9,715 ------------------------------------------------------------------------- GROSS PROFIT $1,202 $2,326 $2,349 $3,632 ------------------------------------------------------------------------- GROSS MARGIN 26% 41% 30% 37% ------------------------------------------------------------------------- EBITDA(1) (excluding gains and losses on foreign exchange) $(323) $457 $(809) $430 ------------------------------------------------------------------------- NET LOSS $(514) $(239) $(1,407) $(664) ------------------------------------------------------------------------- BASIC AND DILUTED LOSS PER SHARE $(0.04) $(0.02) $(0.12) $(0.06) ------------------------------------------------------------------------- 

 ----------------------------------- Three-months Six-months ended June 30, ended June 30, ------------------------------------------------------------------------- (in thousands of Canadian dollars) 2010 2009 2010 2009 ------------------------------------------------------------------------- Net Loss $(514) $(239) $(1,407) $(664) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Amortization of long-term assets 128 121 252 220 ------------------------------------------------------------------------- Loss (gain) on foreign exchange (96) 424 30 580 ------------------------------------------------------------------------- Accretion of deferred financing and warrant costs 62 54 121 101 ------------------------------------------------------------------------- Interest expense 97 97 195 193 ------------------------------------------------------------------------- Adjusted EBITDA $(323) $457 $(809) $430 -------------------------------------------------------------------------